U.S. House · 118th Congress · H.R. 3093
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Val T. HoyleD-OR-4
- Introduced
- May 5, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (18)
18 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Steve CohenD-TN-9
- Rosa L. DeLauroD-CT-3
- Lloyd DoggettD-TX-37
- Jesús G. "Chuy" GarcíaD-IL-4
- Raúl M. GrijalvaD-AZ-7
- Pramila JayapalD-WA-7
- Marcy KapturD-OH-9
- Ro KhannaD-CA-17
- Eleanor Holmes NortonD-DC-AL
- Chellie PingreeD-ME-1
- Mark PocanD-WI-2
- Janice D. SchakowskyD-IL-9
- Melanie A. StansburyD-NM-1
- Jill N. TokudaD-HI-2
Signed on later
- Greg CasarD-TX-35May 26, 2023
- Mark TakanoD-CA-39June 7, 2023
- Seth MagazinerD-RI-2June 13, 2023
- Rashida TlaibD-MI-12August 4, 2023